|
|
|
|
|
|
|
|
update National Cancer Institute
Changes to This Summary (12/23/2016)
Revised a standard treatment option
for advanced-stage ovarian epithelial cancer, FTC, and PPC to surgery
followed by chemotherapy and poly (ADP-ribose) polymerase (PARP)
inhibitors.
The Surgery followed by chemotherapy and PARP inhibitors subsection was extensively revised.
This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is
editorially independent of NCI. The summary reflects an independent review of
the literature and does not represent a policy statement of NCI or NIH. More
information about summary policies and the role of the PDQ Editorial Boards in
maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.